# FDA Inspection 1020609 - Shilpa Medicare Limited - July 28, 2017

Source: https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/3ddb8f78-d603-4012-b674-1b39a9477513
Source feed: FDA_Inspections

> FDA Inspection 1020609 for Shilpa Medicare Limited on July 28, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1020609
- Company Name: Shilpa Medicare Limited
- Inspection Date: 2017-07-28
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1293586 - 2025-11-21](https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/5e052bfe-bb5b-4f70-9128-9b00c83ba684)
- [FDA Inspection 1121634 - 2020-02-25](https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/697d1298-32ab-4346-bb72-ace82de70319)
- [FDA Inspection 1101543 - 2019-09-06](https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/37e8cb63-4ef0-4357-8cf0-a688ed79fa1e)
- [FDA Inspection 1036712 - 2017-11-30](https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/11c5330b-3d05-4b5e-9662-f17cadc816a0)
- [FDA Inspection 983085 - 2016-07-26](https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/79a1c789-9957-4ef8-a691-bc2336167ab0)

Company: https://www.keypedia.com/companies/shilpa-medicare-limited/9184777f-89bb-4a33-bcb2-4cc2aa4eb655

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c